BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirshberg B, Cochran C, Skarulis MC, Libutti SK, Alexander HR, Wood BJ, Chang R, Kleiner DE, Gorden P. Malignant insulinoma: spectrum of unusual clinical features. Cancer. 2005;104:264-272. [PMID: 15937909 DOI: 10.1002/cncr.21179] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Miranda G. Malignant insulinoma chemotherapy resistant, pancreatic neuroendocrine tumor of uncertain prognosis. Journal of Clinical and Translational Endocrinology: Case Reports 2018;8:16-8. [DOI: 10.1016/j.jecr.2018.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Chihaoui M, Hmaissi R, Abid M, Chaieb L, Ben Abdallah N, Zaouech A, Houman H, Rokbani L, Slimane H. Management of insulinoma: Tunisians' experience. Pancreas 2012;41:807-9. [PMID: 22695091 DOI: 10.1097/MPA.0b013e31823b684b] [Reference Citation Analysis]
3 Yu R, Nissen NN, Hendifar A, Tang L, Song Y, Chen Y, Fan X. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series. Pancreas 2017;46:48-56. [DOI: 10.1097/mpa.0000000000000718] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mannelli L, Yeh MM, Wang CL. A pregnant patient with hypoglycemia. Gastroenterology. 2012;143:e3-e4. [PMID: 22921669 DOI: 10.1053/j.gastro.2012.03.051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
5 Teunissen JJM, Kwekkeboom DJ, Valkema R, Krenning EP. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours. Endocrine-Related Cancer 2011;18:S27-51. [DOI: 10.1530/erc-10-0282] [Cited by in Crossref: 81] [Cited by in F6Publishing: 20] [Article Influence: 7.4] [Reference Citation Analysis]
6 Di Martino M, García Sanz I, Delgado Valdueza J, Martín-Pérez E. Giant Malignant Insulinoma. J Gastrointest Surg 2016;20:1530-1. [PMID: 26969167 DOI: 10.1007/s11605-016-3118-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Shankar N, Linzay C, Rowe K. Vasoactive intestinal peptide-oma causing refractory diarrhea in a young woman. Proc (Bayl Univ Med Cent). 2020;33:641-643. [PMID: 33100555 DOI: 10.1080/08998280.2020.1778963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, Parkkola R, Solin O, Bergman J, Sane T, Salmi J, Välimäki M, Nuutila P. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients. J Clin Endocrinol Metab 2007;92:1237-44. [PMID: 17227804 DOI: 10.1210/jc.2006-1479] [Cited by in Crossref: 108] [Cited by in F6Publishing: 83] [Article Influence: 7.2] [Reference Citation Analysis]
9 Sada A, Yamashita TS, Glasgow AE, Habermann EB, Thompson GB, Lyden ML, Dy BM, Halfdanarson TR, Vella A, McKenzie TJ. Comparison of benign and malignant insulinoma. Am J Surg 2021;221:437-47. [PMID: 32873371 DOI: 10.1016/j.amjsurg.2020.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Thomas J, Kumar SC. Nonislet cell tumor hypoglycemia. Case Rep Endocrinol. 2013;2013:308086. [PMID: 24194988 DOI: 10.1155/2013/308086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
11 Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol. 2010;6:229-237. [PMID: 20146582 DOI: 10.2217/fon.09.165] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
12 Shiozaki H, Shirai Y, Horiuchi T, Yasuda J, Furukawa K, Onda S, Gocho T, Shiba H, Ikegami T. Feasible laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors. Mol Clin Oncol 2021;14:111. [PMID: 33903817 DOI: 10.3892/mco.2021.2273] [Reference Citation Analysis]
13 Yu J, Ping F, Zhang H, Li W, Yuan T, Fu Y, Feng K, Xia W, Xu L, Li Y. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades. BMC Endocr Disord. 2018;18:92. [PMID: 30522468 DOI: 10.1186/s12902-018-0321-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
14 Sacco Casamassima MG, Gause CD, Goldstein SD, Abdullah F, Meoded A, Lukish JR, Wolfgang CL, Cameron J, Hackam DJ, Hruban RH, Colombani PM. Pancreatic surgery for tumors in children and adolescents. Pediatr Surg Int 2016;32:779-88. [PMID: 27364750 DOI: 10.1007/s00383-016-3925-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
15 Naganuma A, Mayahara H, Morizane C, Ito Y, Hagihara A, Kondo S, Ueno H, Itami J, Okusaka T. Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases. Jpn J Clin Oncol 2012;42:640-5. [PMID: 22525212 DOI: 10.1093/jjco/hys055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Gu W, Liu Y, Liu H, Yang G, Guo Q, Du J, Jin N, Zang L, Lv Z, Ba J, Mu Y, Dou J. Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma. Diabetol Metab Syndr 2017;9:17. [PMID: 28293303 DOI: 10.1186/s13098-017-0215-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Luu AM, Herzog T, Uhl W, Braumann C. Liver Metastases 10 Years after Resection of a “Benign” Insulinoma. The American Surgeon 2016;82:326-7. [DOI: 10.1177/000313481608201114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Corrias G, Monti S, Horvat N, Tang L, Basturk O, Saba L, Mannelli L. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation. Clin Imaging 2018;51:59-64. [PMID: 29448120 DOI: 10.1016/j.clinimag.2018.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Nastos C, Giannoulopoulos D, Dellaportas D, Mizamtsidi M, Dafnios N, Klonaris N, Kalogeris N, Vryonidou A. Sudden 'cure' of type two diabetes due to pancreatic insulinoma: A case report. Mol Clin Oncol 2020;12:174-8. [PMID: 31929890 DOI: 10.3892/mco.2019.1957] [Reference Citation Analysis]
20 Zerbi A, Capitanio V, Boninsegna L, Pasquali C, Rindi G, Delle Fave G, Del Chiaro M, Casadei R, Falconi M. Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases. Langenbecks Arch Surg. 2011;396:313-321. [PMID: 20857140 DOI: 10.1007/s00423-010-0712-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
21 Linch F, Thompson S, Fleming C, Vella A, Andrews J. Hepatic Artery Embolization for Palliation of Symptomatic Hypoglycemia in Patients With Hepatic Insulinoma Metastases. J Endocr Soc 2021;5:bvab149. [PMID: 34877442 DOI: 10.1210/jendso/bvab149] [Reference Citation Analysis]
22 Zhou W, Gong L, Li X, Wan Y, Wang X, Li H, Jiang B. Screening key candidate genes and pathways involved in insulinoma by microarray analysis. Medicine (Baltimore) 2018;97:e10826. [PMID: 29851790 DOI: 10.1097/MD.0000000000010826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ambrosini V, Campana D, Nanni C, Marzola MC, Rubello D, Fanti S. 68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. Clinical Nuclear Medicine 2015;40:e132-3. [DOI: 10.1097/rlu.0000000000000447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
24 Ciacciarelli M, Caruso G, Rengo M, Maceroni P, Misurale C, D'Armiento E, Polidoro A, Napoli C, Lombardini A, Ceratti U, Colunga Biancatelli RML, Calvosa L, Milanese R, Ferri S, Massaro T, Lorusso A, Sorrentino V, Petrozza V, Iuliano L. Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia. Case Rep Endocrinol 2020;2020:4239679. [PMID: 32082648 DOI: 10.1155/2020/4239679] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Sada A, Glasgow AE, Vella A, Thompson GB, McKenzie TJ, Habermann EB. Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor. World J Surg 2020;44:2288-94. [PMID: 32128613 DOI: 10.1007/s00268-020-05445-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Caliri M, Verdiani V, Mannucci E, Briganti V, Landoni L, Esposito A, Burato G, Rotella CM, Mannelli M, Peri A. A case of malignant insulinoma responsive to somatostatin analogs treatment. BMC Endocr Disord 2018;18:98. [PMID: 30591061 DOI: 10.1186/s12902-018-0325-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
27 Hasani-Ranjbar S, Amoli MM, Ebrahim-Habibi A, Gozashti MH, Khalili N, Sayyahpour FA, Hafeziyeh J, Soltani A, Larijani B. A new frameshift MEN1 gene mutation associated with familial malignant insulinomas. Fam Cancer. 2011;10:343-348. [PMID: 21184284 DOI: 10.1007/s10689-010-9412-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
28 Kopfstein L, Veikkola T, Djonov VG, Baeriswyl V, Schomber T, Strittmatter K, Stacker SA, Achen MG, Alitalo K, Christofori G. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol. 2007;170:1348-1361. [PMID: 17392173 DOI: 10.2353/ajpath.2007.060835] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 6.3] [Reference Citation Analysis]
29 Spada F, Rossi RE, Kara E, Laffi A, Massironi S, Rubino M, Grimaldi F, Bhoori S, Fazio N. Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals (Basel) 2021;14:539. [PMID: 34199977 DOI: 10.3390/ph14060539] [Reference Citation Analysis]
30 Ademoğlu E, Unlütürk U, Ağbaht K, Karabork A, Corapçioğlu D. Type 2 diabetes mellitus in a patient with malignant insulinoma manifesting following surgery. Diabet Med 2012;29:e133-7. [PMID: 22313044 DOI: 10.1111/j.1464-5491.2012.03603.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
31 Herreros-Villanueva M, Hijona E, Cosme A, Bujanda L. Spontaneous regression of pancreatic cancer: Real or a misdiagnosis? World J Gastroenterol 2012; 18(23): 2902-2908 [PMID: 22736913 DOI: 10.3748/wjg.v18.i23.2902] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Ferrer-García JC, Iranzo González-Cruz V, Navas-DeSolís S, Civera-Andrés M, Morillas-Ariño C, Merchante-Alfaro A, Caballero-Díaz C, Sánchez-Juan C, Camps Herrero C. Management of malignant insulinoma. Clin Transl Oncol 2013;15:725-31. [PMID: 23460559 DOI: 10.1007/s12094-012-0996-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
33 Zerbi A, Falconi M, Rindi G, Delle Fave G, Tomassetti P, Pasquali C, Capitanio V, Boninsegna L, Di Carlo V. Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol. 2010;105:1421-1429. [PMID: 20087335 DOI: 10.1038/ajg.2009.747] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 8.1] [Reference Citation Analysis]
34 Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15:409-427. [PMID: 18508996 DOI: 10.1677/erc-07-0221] [Cited by in Crossref: 235] [Cited by in F6Publishing: 101] [Article Influence: 16.8] [Reference Citation Analysis]
35 Fleseriu M, Skugor M, Chinnappa P, Siraj ES. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide. Endocr Pract 2006;12:635-40. [PMID: 17229659 DOI: 10.4158/EP.12.6.635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
36 Nakakura EK, Bergsland EK. Islet Cell Carcinoma: Neuroendocrine Tumors of the Pancreas and Periampullary Region. Hematology/Oncology Clinics of North America 2007;21:457-73. [DOI: 10.1016/j.hoc.2007.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
37 Ro C, Chai W, Yu VE, Yu R. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Chin J Cancer. 2013;32:312-324. [PMID: 23237225 DOI: 10.5732/cjc.012.10295] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
38 Guettier J, Gorden P. Hypoglycemia. Endocrinology and Metabolism Clinics of North America 2006;35:753-66. [DOI: 10.1016/j.ecl.2006.09.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
39 Jyotsna VP, Malik E, Birla S, Sharma A. Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study. BMC Endocr Disord 2015;15:44. [PMID: 26307114 DOI: 10.1186/s12902-015-0041-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Eichelberger GS, Carbono J, Field Z, Kainaur K, Montalvo F. Case Report and Literature Review of Insulinoma in the Geriatric Population: An 86-Year-Old Female with Syncope of Unknown Origin. Case Rep Endocrinol 2020;2020:8879776. [PMID: 32733714 DOI: 10.1155/2020/8879776] [Reference Citation Analysis]
41 Zumsteg A, Strittmatter K, Klewe-nebenius D, Antoniadis H, Christofori G. A bioluminescent mouse model of pancreatic β-cell carcinogenesis. Carcinogenesis 2010;31:1465-74. [DOI: 10.1093/carcin/bgq109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
42 Munir A, Choudhary P, Harrison B, Heller S, Newell-Price J. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol (Oxf). 2008;68:912-918. [PMID: 18088393 DOI: 10.1111/j.1365-2265.2007.03161.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
43 Gaballa D, Abendroth CS, Moyer MT. Alcohol-free EUS-guided chemoablation of multiple pancreatic insulinomas. Endosc Int Open 2019;7:E186-8. [PMID: 30705951 DOI: 10.1055/a-0764-4736] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Gunvén P. Liver embolizations in oncology: A review: Part I. Arterial (chemo)embolizations. Med Oncol 2008;25:1-11. [DOI: 10.1007/s12032-007-0039-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Atwell TD, Lloyd RV, Nagorney DM, Fidler JL, Andrews JC, Reading CC. Peritumoral steatosis associated with insulinomas: appearance at imaging. Abdom Imaging 2008;33:571-4. [DOI: 10.1007/s00261-007-9278-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
46 Antonakis PT, Ashrafian H, Martinez-Isla A. Pancreatic insulinomas: Laparoscopic management. World J Gastrointest Endosc 2015; 7(16): 1197-1207 [PMID: 26566426 DOI: 10.4253/wjge.v7.i16.1197] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
47 Tóth M, Szücs N, Jakab Z, Doros A, Nemes Z, Rácz K. [Malignant insulinoma]. Orv Hetil 2011;152:398-402. [PMID: 21354956 DOI: 10.1556/OH.2011.29058] [Reference Citation Analysis]
48 Ames A, Lago-Hernandez CA, Grunvald E. Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports. J Endocr Soc 2019;3:1417-22. [PMID: 31286108 DOI: 10.1210/js.2019-00097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
49 Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; pour la Société française d’endocrinologie et le Groupe d’étude des tumeurs endocrines. [Malignant insulinoma: recommendations for workup and treatment]. Presse Med 2014;43:645-59. [PMID: 24857257 DOI: 10.1016/j.lpm.2013.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
50 Jensen RT, Norton JA. Endocrine Tumors of the Pancreas and Gastrointestinal Tract. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 491-522.e7. [DOI: 10.1016/b978-1-4160-6189-2.00032-9] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
51 Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 2009;6:419-28. [DOI: 10.1038/nrclinonc.2009.82] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]
52 Jerraya H, Zidi-Mouaffek Y, Dokmak S, Dziri C. Insulinoma with focal hepatic lesions: malignant insulinoma? BMJ Case Rep 2015;2015:bcr2015212811. [PMID: 26670896 DOI: 10.1136/bcr-2015-212811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Vanderveen K, Grant C. Insulinoma. Cancer Treat Res. 2010;153:235-252. [PMID: 19957228 DOI: 10.1007/978-1-4419-0857-5_13] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
54 Fernández-Cruz L, Blanco L, Cosa R, Rendón H. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg. 2008;32:904-917. [PMID: 18264824 DOI: 10.1007/s00268-008-9467-2] [Cited by in Crossref: 141] [Cited by in F6Publishing: 113] [Article Influence: 10.1] [Reference Citation Analysis]
55 Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K. Diagnosis and management of insulinoma. World J Gastroenterol 2013; 19(6): 829-837 [PMID: 23430217 DOI: 10.3748/wjg.v19.i6.829] [Cited by in CrossRef: 152] [Cited by in F6Publishing: 115] [Article Influence: 16.9] [Reference Citation Analysis]
56 Davi MV, Pia A, Guarnotta V, Pizza G, Colao A, Faggiano A; NIKE Group. The treatment of hyperinsulinemic hypoglycaemia in adults: an update. J Endocrinol Invest 2017;40:9-20. [PMID: 27624297 DOI: 10.1007/s40618-016-0536-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
57 Yadav RS, Pokharel A, Gaire D, Shrestha S, Pokharel A, Pradhan S, Kansakar PBS. Multiple Endocrine Neoplasia Type 1 with Concomitant Existence of Malignant Insulinoma: A Rare Finding. Case Rep Endocrinol 2021;2021:8842667. [PMID: 34367700 DOI: 10.1155/2021/8842667] [Reference Citation Analysis]
58 Guettier JM, Gorden P. Insulin secretion and insulin-producing tumors. Expert Rev Endocrinol Metab. 2010;5:217-227. [PMID: 20401170 DOI: 10.1586/eem.09.83] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
59 Schmitt J, Boullu-sanchis S, Moreau F, Drui S, Louis B, Chabrier G, Pinget M, Jeandidier N. Association of malignant insulinoma and type 2 diabetes mellitus: A case report. Annales d'Endocrinologie 2008;69:69-72. [DOI: 10.1016/j.ando.2007.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
60 Poku C, Amjed H, Kazi F, Samarasinghe S. Metastatic insulinoma presenting after bariatric surgery in a patient diagnosed with MEN1. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5419] [Reference Citation Analysis]
61 Asban A, Patel AJ, Reddy S, Wang T, Balentine CJ, Chen H. Cancer of the Endocrine System. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1074-1107.e11. [DOI: 10.1016/b978-0-323-47674-4.00068-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Dudum R, Murthy VK. Keeping a Low Profile: Insulinoma. Am J Med 2019;132:1160-2. [PMID: 31054830 DOI: 10.1016/j.amjmed.2019.04.017] [Reference Citation Analysis]
63 Anthony LB. Practical guide to supportive care of patients with functional neuroendocrine tumors. Semin Oncol. 2013;40:45-55. [PMID: 23391112 DOI: 10.1053/j.seminoncol.2012.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
64 Liu GQ, Qiu FB, Qu YH, Liu N. Epidemiological features, diagnosis and treatment of insulinoma: an analysis of 3 524 cases. Shijie Huaren Xiaohua Zazhi 2010; 18(15): 1620-1623 [DOI: 10.11569/wcjd.v18.i15.1620] [Reference Citation Analysis]
65 Oberg K. Pancreatic endocrine tumors. Semin Oncol. 2010;37:594-618. [PMID: 21167379 DOI: 10.1053/j.seminoncol.2010.10.014] [Cited by in Crossref: 118] [Cited by in F6Publishing: 96] [Article Influence: 10.7] [Reference Citation Analysis]
66 Zandee WT, Kamp K, van Adrichem RC, Feelders RA, de Herder WW. Effect of hormone secretory syndromes on neuroendocrine tumor prognosis. Endocr Relat Cancer. 2017;24:R261-R274. [PMID: 28483790 DOI: 10.1530/erc-16-0538] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
67 Liu H, Zhang S, Wu Y, Fang H, Li J, Sheng H, Wang Y. Diagnosis and surgical treatment of pancreatic endocrine tumors in 36 patients: a single-center report: . Chinese Medical Journal 2007;120:1487-90. [DOI: 10.1097/00029330-200709010-00004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Callacondo D, Arenas JL, Ganoza AJ, Rojas-camayo J, Quesada-olarte J, Robledo H. Giant Insulinoma: A Report of 3 Cases and Review of the Literature. Pancreas 2013;42:1323-32. [DOI: 10.1097/mpa.0b013e318292006a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
69 Costa FP, Gumz B, Pasche B. Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2012;26:843-54. [PMID: 23582923 DOI: 10.1016/j.bpg.2012.12.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
70 Kurakawa KI, Okada A, Manaka K, Konishi T, Jo T, Ono S, Uda K, Michihata N, Matsui H, Fushimi K, Yamaguchi S, Yamauchi T, Nangaku M, Yasunaga H, Kadowaki T. Clinical characteristics and incidences of benign and malignant insulinoma using a national inpatient database in Japan. J Clin Endocrinol Metab 2021:dgab559. [PMID: 34343300 DOI: 10.1210/clinem/dgab559] [Reference Citation Analysis]
71 Perez K, Chan J. Treatment of Gastroenteropancreatic Neuroendocrine Tumors. Surgical Pathology Clinics 2019;12:1045-53. [DOI: 10.1016/j.path.2019.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Healy ML, Dawson SJ, Murray RM, Zalcberg J, Jefford M. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma. Intern Med J. 2007;37:406-409. [PMID: 17535385 DOI: 10.1111/j.1445-5994.2007.01371.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
73 Peppa M, Brountzos E, Economopoulos N, Boutati E, Pikounis V, Patapis P, Economopoulos T, Raptis SA, Hadjidakis D. Embolization as an alternative treatment of insulinoma in a patient with multiple endocrine neoplasia type 1 syndrome. Cardiovasc Intervent Radiol. 2009;32:807-811. [PMID: 19184198 DOI: 10.1007/s00270-008-9499-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
74 Hackeng WM, Schelhaas W, Morsink FHM, Heidsma CM, van Eeden S, Valk GD, Vriens MR, Heaphy CM, Nieveen van Dijkum EJM, Offerhaus GJA, Dreijerink KMA, Brosens LAA. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas. Endocr Pathol 2020;31:108-18. [PMID: 32103422 DOI: 10.1007/s12022-020-09611-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
75 Moreira RO, Moreira RB, Machado NA, Gonçalves TB, Coutinho WF. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 2008;18:1618-21. [PMID: 18566871 DOI: 10.1007/s11695-008-9569-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 6.1] [Reference Citation Analysis]
76 Casanova D, Polavieja MG, Naranjo A, Pardo F, Rotellar F, Gonzalez F, Luzuriaga C, Regaño S, Freijanes J. Surgical treatment of persistent hyperinsulinemic hypoglycemia (PHH) (insulinoma and nesidioblastosis). Langenbecks Arch Surg 2007;392:663-70. [DOI: 10.1007/s00423-007-0158-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
77 Padidela R, Fiest M, Arya V, Smith VV, Ashworth M, Rampling D, Newbould M, Batra G, James J, Wright NB, Dunne MJ, Clayton PE, Banerjee I, Hussain K. Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients. European Journal of Endocrinology 2014;170:741-7. [DOI: 10.1530/eje-13-1008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
78 Diaconescu S, Gîlcă-Blanariu GE, Poamaneagra S, Marginean O, Paduraru G, Stefanescu G. Could the burden of pancreatic cancer originate in childhood? World J Gastroenterol 2021; 27(32): 5322-5340 [PMID: 34539135 DOI: 10.3748/wjg.v27.i32.5322] [Reference Citation Analysis]
79 Briganti V, Cuccurullo V, Di Stasio GD, Mansi L. Gamma Emitters in Pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides? CRP 2019;12:156-70. [DOI: 10.2174/1874471012666190301122524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Ielpo B, Caruso R, Ferri V, Quijano Y, Duran H, Diaz E, Fabra I, Puga R, Oliva C, Olivares S, Vicente E. Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review. Int J Surg Case Rep 2013;4:265-8. [PMID: 23333851 DOI: 10.1016/j.ijscr.2012.11.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
81 Câmara-de-Souza AB, Toyoshima MTK, Giannella ML, Freire DS, Camacho CP, Lourenço DM Jr, Rocha MS, Bacchella T, Jureidini R, Machado MCC, Almeida MQ, Pereira MAA. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors. Pancreatology 2018;18:298-303. [PMID: 29452754 DOI: 10.1016/j.pan.2018.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
82 Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin North Am. 2009;89:1105-1121. [PMID: 19836487 DOI: 10.1016/j.suc.2009.06.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
83 Lorenzo-Villalba N, Maouche Y, Alonso Ortiz MB, Zulfiqar AA. [Complexity of the management of an insulinoma in a nonagenarian patient]. Rev Esp Geriatr Gerontol 2021;56:63-4. [PMID: 33303259 DOI: 10.1016/j.regg.2020.09.005] [Reference Citation Analysis]
84 Liu H, Peng C, Zhang S, Wu Y, Fang H, Sheng H, Peng S. Strategy for the surgical management of insulinomas: analysis of 52 cases. Dig Surg. 2007;24:463-470. [PMID: 18057893 DOI: 10.1159/000111822] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
85 Singbo J, Locketz M, Ross IL. Challenge of coexisting type 2 diabetes mellitus and insulinoma: a case report. J Med Case Rep 2021;15:479. [PMID: 34583764 DOI: 10.1186/s13256-021-03047-2] [Reference Citation Analysis]
86 Tachibana T, Kasajima A, Aoki T, Tabata T, McNamara K, Yazdani S, Satoko S, Fujishima F, Motoi F, Unno M, Sasano H. Progesteron receptor expression in insulin producing cells of neuroendocrine neoplasms. J Steroid Biochem Mol Biol 2020;201:105694. [PMID: 32437964 DOI: 10.1016/j.jsbmb.2020.105694] [Reference Citation Analysis]
87 Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; Société française d’endocrinologie., Groupe d’étude des tumeurs endocrines. Malignant insulinoma: recommendations for characterisation and treatment. Ann Endocrinol (Paris) 2013;74:523-33. [PMID: 23993836 DOI: 10.1016/j.ando.2013.07.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
88 Furnica RM, Istasse L, Maiter D. A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma. Ann Endocrinol (Paris) 2018;79:30-6. [PMID: 29241949 DOI: 10.1016/j.ando.2017.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
89 Sawyer AM, Schade DS. Use of a continuous glucose monitor in the management of inoperable metastatic insulinoma: a case report. Endocr Pract 2008;14:880-3. [PMID: 18996817 DOI: 10.4158/EP.14.7.880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
90 Gao LP, Kong GX, Wang X, Ma HM, Ding FF, Li TD. Pancreatic neuroendocrine carcinoma in a pregnant woman: A case report and review of the literature . World J Clin Cases 2021; 9(17): 4327-4335 [PMID: 34141797 DOI: 10.12998/wjcc.v9.i17.4327] [Reference Citation Analysis]